Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-21

Clinical Trial Update: Neuroprotective Effects of Hypothermia Combined With Inhaled Xenon Following Perinatal Asphyxia [NA]

View source ↗

Summary

A completed clinical trial evaluating neuroprotective effects of hypothermia combined with inhaled xenon for hypoxic ischaemic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hypothermia (therapeutic hypothermia)
  • inhaled xenon (xenon)

Snippet

Sponsor: Imperial College London | Conditions: Hypoxic Ischaemic Encephalopathy | NA | Status: COMPLETED | Results posted: 2022-04-21